for Journals by Title or ISSN
for Articles by Keywords
help
Journal Cover JAMA Internal Medicine
  [SJR: 5.955]   [H-I: 272]   [257 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 2168-6106 - ISSN (Online) 2168-6114
   Published by American Medical Association Homepage  [13 journals]
  • February 2018 Issue Highlights
    • PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Four Archetypes to Help Mentees Succeed in Academic Medicine
    • Authors: Chopra V; Arora VM, Saint S.
      Abstract: This Viewpoint defines 4 mentorship models in academic medicine and discusses how mentees can maximize the yield of each.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Reform of the National Screening Mammography Program in France
    • Authors: Barratt A; Jørgensen K, Autier P.
      Abstract: This Viewpoint reviews the reasons and process for a recent national civil dialogue in France to reform the national screening mammography program.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Selling Patents to Indian Tribes to Delay Market Entry of Generic Drugs
    • Authors: Ablavsky G; Larrimore Ouellette L.
      Abstract: This Viewpoint explores the drug company practice of selling patents to Indian tribes—sovereign legal entities—to delay the market entry of generic drugs.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • A Clear-eyed View of Restasis and Chronic Dry Eye Disease
    • Authors: Schwartz LM; Woloshin S.
      Abstract: This Viewpoint examines the cost and efficacy of Restasis (cyclosporine ophthalmic emulsion, 0.05%) for the treatment of dry eye disease.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Dying at Home—Our Grandfather’s Great Escape
    • Authors: Chin-Yee B; Chin-Yee N.
      Abstract: In this Perspective, the authors reflect on their grandfather’s journey home from the hospital for a “good death” and lessons for end-of-life care.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Use of Postmenopausal Hormone Therapy to Prevent Chronic Conditions
    • Authors: Grady D.
      Abstract: In the current issue of JAMA, the US Preventive Services Task Force reiterates and updates their recommendation that asymptomatic postmenopausal women should not take hormone therapy (HT) to prevent chronic conditions.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Quality Improvement for Quality Improvement Studies
    • Authors: Grady D; Redberg RF, O’Malley PG.
      Abstract: At JAMA Internal Medicine, we receive many manuscripts describing studies designed to improve health care quality, safety, or value. We applaud these efforts, as we strongly believe that changes in health care delivery and process should be driven by evidence. We also believe, however, that it is time to raise the bar on the methods, analysis, and reporting of quality improvement studies, as well as the threshold for those that are worthy of publication in this journal.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Emergency-Only vs Standard Hemodialysis Among Undocumented Immigrants With
           ESRD
    • Authors: Cervantes L; Tuot D, Raghavan R, et al.
      Abstract: This cohort study examines whether mortality and health care use differs among undocumented immigrants who receive standard hemodialysis (3 times weekly at a health care center) vs emergency-only hemodialysis.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Hospitalist Years of Experience and Patient Mortality
    • Authors: Goodwin JS; Salameh H, Zhou J, et al.
      Abstract: This cohort study of Medicare data describes the association of hospitalist years of experience with 30-day mortality and hospital mortality of their patients.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Outcomes Among LVAD Recipients With and Without ESRD
    • Authors: Bansal N; Hailpern SM, Katz R, et al.
      Abstract: This cohort study uses data from the United States Renal Data System to determine the utilization of and outcomes associated with left ventricular assist devices in nationally representative cohorts of patients with and without end-stage renal disease.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Noninvasive Cardiac Testing vs Clinical Evaluation Alone
    • Authors: Reinhardt SW; Lin C, Novak E, et al.
      Abstract: This secondary analysis of data from a randomized clinical trial examines differences in outcomes with clinical evaluation and noninvasive testing vs clinical evaluation alone.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Regional Variation of Computed Tomographic Imaging and the Risk of
           Nephrectomy
    • Authors: Welch H; Skinner JS, Schroeck FR, et al.
      Abstract: This cross-sectional analysis of 15 million fee-for-service Medicare beneficiaries age 65 to 85 years examines the geographic variation in use of computed tomography imaging and its association with risk of nephrectomy.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Cardiovascular Risk and Inhaled Long-Acting Bronchodilators
    • Authors: Wang M; Liou J, Lin C, et al.
      Abstract: This nested case-control study investigates the risk of cardiovascular disease associated with long-acting β2-agonists and long-acting antimuscarinic antagonists, focusing on the initiation and duration of both therapies.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Comparing Physician Visual Assessment and Quantitative Coronary
           Angiography in Assessment of Stenosis Severity in China
    • Authors: Zhang H; Mu L, Hu S, et al.
      Abstract: This cross-sectional study examines the accuracy of physician visual assessment vs quantitative coronary angiography in the interpretation of coronary stenosis severity among adults undergoing percutaneous coronary intervention in China.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in
           Older Adults
    • Authors: Le P; Rothberg MB.
      Abstract: This modeling study based on randomized clinical trial data assesses the cost-effectiveness of the adjuvanted herpes zoster subunit vaccine.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Association of Hospital Global Budgets With Changes in Health Care Use
    • Authors: Roberts ET; McWilliams J, Hatfield LA, et al.
      Abstract: This study evaluates Maryland’s hospital global budget program during its first 2 years by comparing changes in hospital and primary care use among fee-for-service Medicare beneficiaries in 8 Maryland counties vs 27 matched control non-Maryland counties.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • The Renal Challenge With Left Ventricular Assist Device Therapy
    • Authors: Thomas SS; Zern EK, D’Alessandro DA.
      Abstract: Nearly 2 decades after the seminal REMATCH trial first demonstrated a marginal survival benefit in transplant-ineligible patients treated with an implantable left ventricular assist device (LVAD), contemporary 1-year LVAD survival exceeds 80%. With improved outcomes and quality of life, LVAD use has proliferated, with more than 15 000 implantations since 2006 and an annual implantation rate exceeding 2000 per year across an ever-growing number of implanting centers. While most current LVADs are implanted as a bridge to cardiac transplantation, an increasing proportion of patients with end-stage heart failure are consenting to indefinite mechanical circulatory support (MCS) therapy. With an increasing prevalence of advanced heart failure in an aging population, this trend is expected to continue.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Not-So-Incidental Harms of Incidental Findings
    • Authors: Smith-Bindman R.
      Abstract: Use of advanced imaging tests is high. For every 100 Medicare beneficiaries 65 years or older, more than 50 computed tomography (CT) scans, 50 ultrasonography scans, 15 magnetic resonance imaging scans, and 10 positron emission tomography scans are performed annually. These numbers have more than tripled since 1997.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Evolution of Herpes Zoster Vaccines and Their Economic Value
    • Authors: Najafzadeh M.
      Abstract: Herpes zoster (HZ) affects almost 1 in 3 adults in the United States during their lifetime. The disease often causes severe pain that may last for a few weeks, with substantial influence on individuals’ quality of life, daily activities, and work. Some patients continue to experience debilitating pain for more than a year, a complication that is known as postherpetic neuralgia (PHN). Serious cases can involve the eyes and central nervous system disease.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Maryland’s All-Payer Health Reform
    • Authors: Sharfstein JM; Stuart EA, Antos J.
      Abstract: In January 2014, the State of Maryland and the Centers for Medicare and Medicaid Services (CMS) came to terms on an ambitious approach to improve care for Marylanders and to slow the growth of health care costs. The state shifted from its historic approach of limiting price growth by setting hospital rates for all payers to limiting overall hospital expenditures by establishing global hospital budgets. A second phase that broadens the policy scope to the total cost of care, including hospital and nonhospital spending, is expected to begin in 2019.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Acute Chest Pain in the Emergency Department
    • Authors: Curfman G.
      Abstract: In 2014, a total of 6 887 000 patients came to US emergency departments (EDs) because of symptoms of chest pain, representing 5% of all ED visits. While some of them have clinical evidence of acute coronary syndromes (ACS), many others have no ischemic changes on the electrocardiogram (ECG) and normal cardiac troponin levels. Uncertainty surrounds proper treatment of these low- to intermediate-risk patients.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Overuse of Percutaneous Coronary Interventions
    • Authors: Redberg RF.
      Abstract: Since Gruentzig first used a balloon to inflate the left anterior descending of a young man with angina in 1977, there have been hundreds of millions of percutaneous coronary interventions (PCI) done worldwide. Most PCI are performed on patients who are asymptomatic or who have not had a trial of optimal medical therapy, which is equally effective in preventing myocardial infarction or death. Furthermore, in symptomatic patients there is no benefit to PCI in reducing symptoms or improving quality of life compared with a placebo procedure. This carefully performed analysis from the China PEACE study adds to the concern of overuse of PCI. It documents yet another commonly known but little discussed contributor to inappropriate PCI—the inaccuracy of angiographic readings. Visual assessments tend to systematically overestimate the magnitude of the stenosis, meaning that patients will get an intervention on a lesion that is not hemodynamically significant. In a painstaking analysis of 1295 patients who underwent PCI in China, Zhang et al compared physician visual assessment with quantitative coronary angiography (QCA). They found systematic overestimation of angiographic stenosis by 10% for patients with acute myocardial infarction (AMI), and 16% for patients without AMI.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Reducing Overtreatment of Asymptomatic Bacteriuria
    • Authors: Daniel M; Keller S, Mozafarihashjin M, et al.
      Abstract: This article proposes an evidence-based implementation guide to aid clinicians in reducing inappropriate treatment of asymptomatic bacteriuria.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Modifiable Risk Factors and Prevention of Dementia
    • Authors: Yaffe K.
      Abstract: This Evidence to Practice review provides a summary and commentary on 2 recent commissioned reports on strategies for preventing and treating dementia.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Edema and Ulceration of the Legs
    • Authors: Yek C; Hendren NS, Dominguez AR.
      Abstract: This Teachable Moment describes the case of a 65-year-old man who presented with symptoms of infection but was found to have a misdiagnosed case of stasis dermatitis.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Blind Obedience and an Unnecessary Workup for Hypoglycemia
    • Authors: Wang EY; Patrick L, Connor DM.
      Abstract: This Teachable Moment examines the danger in overvaluing laboratory test results that contradict clinical findings.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Not Your Typical ST-Elevation Myocardial Infarction
    • Authors: Morehead-Gee A; Padmanabhan A, Goldschlager N.
      Abstract: A man in his 80s with unknown medical history was brought to the emergency department after a cardiac arrest.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Profound Electrocardiogram Changes in a Patient With Liver Cirrhosis
    • Authors: Littmann L; Potter JK, Hoglund JR.
      Abstract: Two years after the diagnosis of cirrhotic-stage primary sclerosing cholangitis, a 41-year-old man underwent successful liver transplantation. Three months later he experienced progressive shortness of breath, chest pain, and episodes of exertional syncope. Of note, during the 2-year pretransplant period, the patient had no cardiac complaints, and an echocardiogram performed a few months before the liver transplantation was normal. Figure 1 demonstrates 2 electrocardiograms (ECGs) of the patient. Figure 1A was obtained before the liver transplantation, and Figure 1B was recorded 3 months after the liver transplantation, on development of new cardiovascular symptoms. Note the profound changes both in the QRS morphologies and the ST-T segments between the 2 ECGs.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Coded Severity and Readmission Reduction After the Hospital Readmissions
           Reduction Program
    • Authors: Ibrahim AM; Dimick JB, Sinha SS, et al.
      Abstract: This study uses the Medicare Provider Analysis and Review file to examine whether coded severity of illness is associated with reduced rates of readmission after implementation of the Hospital Readmissions Reduction Program.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Gabapentinoid Use in the United States 2002 Through 2015
    • Authors: Johansen ME.
      Abstract: This cohort study uses 2002-2015 Medical Expenditure Panel Survey data to characterize the use of gabapentinoids among the US adult population.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Limitations of a Study of People Living With HIV and Lung Cancer
    • Authors: Lai Z; Chhabra S.
      Abstract: To the Editor In an Original Investigation published in a recent issue of JAMA Internal Medicine, Reddy and colleagues used a microsimulation model to calculate cumulative lung cancer mortality in people living with HIV (PLWH) on antiretroviral therapy stratified by age, sex, and smoking exposure.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Limitations of a Study of People Living With HIV and Lung
           Cancer—Reply
    • Authors: Reddy KP; Parker RA, Walensky RP.
      Abstract: In Reply We appreciate the points raised by Lai and Chhabra. Like all models, ours is subject to limitations in studies from which input parameters are derived. As mentioned by Lai and Chhabra, as well as in our own Limitations section, uncertainty exists around the HIV-associated lung cancer (HALC) risk. To inform this parameter, we looked to a report by Sigel et al that compared lung cancer rates between people living with HIV (PLWH) and people who were not infected with HIV, stratified by smoking status. Though there were relatively few women, we selected this study for our base case scenario because it included 457 cases of lung cancer in PLWH, by far the greatest number in any study of HALC risk that simultaneously reported participant smoking status. Engels et al, in a single-center study, reported higher HALC risk in women than in men, though with several important limitations: (1) smoking status was unavailable for most participants; (2) there were only 33 cases of lung cancer in PLWH (11 in women, which was only 2 more than in Sigel et al); (3) in calculating standardized incidence ratios, the authors applied substantially different smoking-associated lung cancer risks for women (12.5) and men (21.3). Contemporary estimates indicate that the smoking-associated lung cancer risk is nearly equivalent between women and men (approximately 25). Thus, the study by Engels et al may have underestimated the smoking-associated risk and overestimated HALC risk in women. We considered this article (it was reference 15 in our study) but because the confidence interval for the ratio of female to male HALC risk included 1.0, and lacking a biologic explanation or other evidence for a difference in HALC risk between women and men, we kept HALC risk equal between the 2 in our base case.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Immortal Time Bias and Staphylococcus aureus Bacteremia
    • Authors: Tong SC; Cheng AC, Denholm JT.
      Abstract: To the Editor The Original Investigation by Goto et al recently published in JAMA Internal Medicine presented the analysis of an impressive data set of 36 868 Staphylococcus aureus bacteremia episodes at Veterans Health Administration hospitals. Goto et al reported that receipt of evidence-based care processes decreased mortality with risk-adjusted odds ratios for mortality of 0.74 (appropriate antibiotics), 0.73 (echocardiography), 0.61 (infectious diseases consultation), and 0.33 (all 3 processes). While these results are striking, we are concerned that immortal time bias has not been properly accounted for in the analysis, which may bias the results in favor of these interventions.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Immortal Time Bias and Staphylococcus aureus Bacteremia—Reply
    • Authors: Goto M; Perencevich EN, Ohl ME.
      Abstract: In Reply Tong et al call attention to the potential for immortal time bias in our analyses of relationships between use of evidence-based care processes and mortality among patients with Staphylococcus aureus bacteremia (SAB). Immortal time bias may occur in cohort studies if there is a period of time when occurrence of the outcome of interest—mortality in our study—prevents patients from experiencing the exposure(s) of interest. In short, associations between use of evidence-based care processes and survival at 30 days may occur because patients who survived longer were more likely to receive the care processes and not because receipt of the care processes extended survival.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Internal Medicine Physicians Compared With Emergency Physicians: Flawed
           Data
    • Authors: Parker R.
      Abstract: To the Editor A study published in a recent issue of JAMA Internal Medicine titled “Variation in Emergency Department vs Internal Medicine Excess Charges in the United States” compares charges for services provided by internal medicine physicians with emergency physicians. There are several important limitations that deserve further consideration.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Internal Medicine Physicians Compared With Emergency Physicians: Flawed
           Data
    • Authors: Xu T; Park A, Bai G.
      Abstract: In Reply We thank Dr Parker for her comments on our study. We acknowledge that emergency departments (EDs) face financial pressures in caring for some of the sickest patients. As the safety net, they shoulder a significant burden of uncompensated care. Under the current system, however, EDs can charge any amount to those who do not have a payor-negotiated rate, namely those who are uninsured and out of network. There have been reports of low-income uninsured patients being pursued by hospital collections agencies for the chargemaster price of care. Moreover, increasing evidence points to the fact that “surprise medical bills” are common for out-of-network patients visiting the ED.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Inconsistent Hypertension Guidelines: Clinicians Need a Little Help Here
    • Authors: Skolnik N.
      Abstract: To the Editor My colleagues and I in primary care are figuring out what to do with the hypertension guidelines announced in November 2017. The guidelines were endorsed by the American College of Cardiology, American Heart Association, American Society for Hypertension, and almost every other cardiology organization in existence. Notably missing among the organizations endorsing the guidelines were the 2 primary care organizations that represent the majority of physicians who actually treat hypertension everyday: the American Academy of Family Physicians (AAFP) and the American College of Physicians (ACP). These organizations issued their own guidelines 6 months earlier, with recommendations for blood pressure management of adults older than 60 years. Those guidelines recommend a target systolic blood pressure of less than 150 mm Hg—distinctly different from the target recommended by the new joint statement, which recommends a target less than 130 mm Hg. This remarkable lack of consensus complicates the decision-making process for practicing clinicians and creates confusion.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • False Information About Breast Cancer Screening
    • Authors: Kopans DB.
      Abstract: To the Editor The Editorial by Grady and Redberg in a recent issue of JAMA Internal Medicine commenting on the Research Letter reporting that physicians are recommending mammography screening for women starting at the age of 40 years contains false information. Grady and Redberg claim that physicians are ignoring the US Preventive Services Task Force (USPSTF), but the USPSTF clearly stated that they “…found adequate evidence that mammography screening reduces breast cancer mortality in women aged 40 to 74 years.”(p280) The American Cancer Society stated, “Women should have the opportunity to begin annual screening between the ages of 40 and 44 years (qualified recommendation).”(p1599) The qualification was not based on science but because they “thought” that some women might want to wait until age 45 years. Physicians should be applauded for understanding that the data clearly show that screening saves lives for women 40 years and older and that there are no scientifically derived data supporting the age of 50 years as a threshold for screening.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • False Information About Breast Cancer Screening
    • Authors: Baker JA.
      Abstract: To the Editor Together, the recent Research Letter by Radhakrishnan and colleagues and the accompanying Editorial by Grady and Redberg, both published in a recent issue of JAMA Internal Medicine, provide strong evidence that primary care physicians recognize the value of screening mammography to improve the lives of their patients. The survey by Radhakrishnan and colleagues reports that most primary care physicians reject the US Preventive Services Task Force (USPSTF) contentious recommendations on screening. Rather, by recommending annual screening for their patients beginning at age 40 years, physicians surveyed in the fields of internal medicine, family medicine, and obstetrics and gynecology demonstrate that their understanding that all major medical organizations that comment on screening—the American Cancer Society (ACS), the American College of Radiology, the Society of Breast Imaging, the American Congress of Obstetricians and Gynecologists, and even the USPSTF itself—all agree that mortality is minimized by beginning annual screening at age 40 years, even though the USPSTF recommends screening begin at 50 years.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • False Information About Breast Cancer Screening
    • Authors: Ozdemir B; Podrazik PM.
      Abstract: To the Editor We appreciate the opportunity to respond to the Editorial by Grady and Redberg published in a recent issue of JAMA Internal Medicine on physician adherence to screening guidelines for breast cancer. Grady and Redberg bring attention to anchoring to age cutoffs set by the US Preventive Services Task Force (USPSTF) as a primary consideration for breast cancer screening. Breast cancer remains in the top 3 causes of death for women ages 35 to 64 years in the United States. Women in this age range are typically wage earners, mothers, caregivers, and spouses. But breast cancer is also a cancer of advancing age, accounting for approximately 60% of cancer deaths in women older than 64 years. Solutions for breast cancer morbidity and mortality are often blurred in the haze of mammography screening debates. Addressing benefit and risk of screening in what constitutes varied populations of women is perhaps the more difficult question at hand. This task remains particularly taxing for women at advanced age, requiring office evaluation that includes stratifying risk according to estimates of remaining life expectancy, burden of chronic disease, and functional status, all aligned with patient wishes.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • False Information About Breast Cancer Screening—Reply
    • Authors: Redberg RF; Grady D.
      Abstract: In Reply Our recent Editorial commented on findings that 81% of surveyed physicians recommended routine screening mammography to women without a personal or family history of breast cancer starting at age 40 years. We found this disappointing, given that the evidence of benefit in women ages 40 to 49 years is weak, but the harms of screening are substantial. Drs Kopans and Baker, both mammographers, disparage our view and claim that we misreported the recommendations of the US Preventive Services Task Force (USPSTF) and American Cancer Society. We correctly state that neither the USPSTF nor the nor American Cancer Society recommend routine breast cancer screening among women between the ages of 40 and 45 years. Both Drs Kopans and Baker bend the meaning of official guidelines statements, for example, stating that the American Cancer Society recommends screening beginning at age 40 years because the recommendation says that “women should have the opportunity to begin annual screening between the ages of 40 and 44 years.”(p1599)
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Misspelled Name and Data Error in Text
    • Abstract: In the article titled “Use of Advanced Imaging Tests and the Not-So-Incidental Harms of Incidental Findings,” the surname of H. Gilbert Welch, MD, MPH—the first author of the Original Investigation referenced in the Invited Commentary—was misspelled. There was also a data error concerning the number of medical specialty societies that contributed recommendations to the American Board of Internal Medicine Foundation’s Choosing Wisely Campaign. The article was corrected online.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • Hudson River, Manhattan
    • Abstract: Courtesy of: Charles Maltz, MD, PhD, Weill Cornell Medical College, 1305 York Ave, 4th Floor, New York, NY 10021.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
  • JAMA Internal Medicine
    • Abstract: Mission Statement: To promote the art and science of medicine and the betterment of human health by publishing manuscripts of interest and relevance to internists practicing as generalists or as medical subspecialists.
      PubDate: Thu, 01 Feb 2018 00:00:00 GMT
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.144.84.155
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-